参考文献
FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
ttps://www.pfizer.com/news/press-release/press-release-detail/fda-approves-pfizers-litfulotm-ritlecitinib-adults-and#:~:text=NEW%20YORK%2D%2D(BUSINESS%20WIRE,older%20with%20severe%20alopecia%20areata.
元論文
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
ttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2823%2900222-2/fulltext
